Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tyme Technologies (TYME)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 242,047
  • Shares Outstanding, K 103,439
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,970 K
  • 60-Month Beta 0.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 15.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.00 +14.50%
on 03/08/19
3.26 -29.75%
on 02/20/19
-0.89 (-27.99%)
since 02/19/19
3-Month
2.00 +14.50%
on 03/08/19
4.12 -44.42%
on 01/15/19
-1.09 (-32.25%)
since 12/19/18
52-Week
1.93 +18.65%
on 11/12/18
4.64 -50.65%
on 12/13/18
+0.04 (+1.78%)
since 03/19/18

Most Recent Stories

More News
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Tyme Technologies, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tyme Technologies, Inc. ("Tyme" or the "Company") (NASDAQ:TYME) of the March 29, 2019 deadline to seek the...

TYME : 2.29 (-2.14%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, TYME, TAP and UMC

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

CORT : 12.21 (-0.81%)
TAP : 60.76 (-0.31%)
TYME : 2.29 (-2.14%)
UMC : 1.86 (+0.54%)
TYME Announces Leadership Team Update

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies, announced a realignment in responsibilities among its leadership team. Effective...

TYME : 2.29 (-2.14%)
EQUITY ALERT: Rosen Law Firm Reminds Tyme Technologies, Inc. Investors of Important Deadline in Securities Class Action Lawsuit - TYME

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tyme Technologies, Inc. (NASDAQ: TYME) from March 14, 2018 through January 18, 2019, inclusive (the "Class Period")...

TYME : 2.29 (-2.14%)
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tyme Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tyme Technologies, Inc. ("Tyme" or "the Company") (NASDAQ: TYME) for violations...

TYME : 2.29 (-2.14%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of TYME, DPLO, CVS and SYNH

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies...

CVS : 57.09 (+0.74%)
SYNH : 51.40 (+8.39%)
TYME : 2.29 (-2.14%)
DPLO : 5.72 (-1.38%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tyme Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline - TYME

Pomerantz LLP announces that a class action lawsuit has been filed against Tyme Technologies, Inc. ("Tyme" or the "Company") (NASDAQ: TYME) and certain of its officers. The class action, filed in United...

TYME : 2.29 (-2.14%)
(TYME) Tyme Technologies, Inc. - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder & Final Deadline March 29, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tyme Technologies, Inc. ("Tyme" or the "Company") (NASDAQ: TYME) and certain...

TYME : 2.29 (-2.14%)
CLASS ACTION UPDATE for TYME, AVEO, CVS and CTL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

AVEO : 0.61 (unch)
CVS : 57.09 (+0.74%)
TYME : 2.29 (-2.14%)
CTL : 11.91 (-1.33%)
SHAREHOLDER ALERT: MAXR MU TYME TAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

TAP : 60.76 (-0.31%)
MU : 40.37 (+1.92%)
TYME : 2.29 (-2.14%)
MAXR : 4.53 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade TYME with:

Business Summary

Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body's immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York.

See More

Key Turning Points

2nd Resistance Point 2.46
1st Resistance Point 2.37
Last Price 2.29
1st Support Level 2.22
2nd Support Level 2.16

See More

52-Week High 4.64
Fibonacci 61.8% 3.60
Fibonacci 50% 3.28
Fibonacci 38.2% 2.97
Last Price 2.29
52-Week Low 1.93

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar